An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer

被引:43
|
作者
Shui, Ruohong [1 ,2 ]
Yu, Baohua [1 ,2 ]
Bi, Rui [1 ,2 ]
Yang, Fei [1 ,2 ]
Yang, Wentao [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 05期
关键词
LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER;
D O I
10.1371/journal.pone.0125131
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer
    Wang, Yi-xing
    Wang, Yuan-yuan
    Yang, Cheng-gang
    Bu, Hong
    Yang, Wen-tao
    Wang, Li
    Xu, Wen-mang
    Zhao, Xi-long
    Zhao, Wen-xing
    Li, Lei
    Song, Shu-ling
    Yang, Ju-lun
    BREAST, 2020, 49 : 225 - 232
  • [2] Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
    Mikami, Yoshiki
    Ueno, Takayuki
    Yoshimura, Kenichi
    Tsuda, Hitoshi
    Kurosumi, Masafumi
    Masuda, Shinobu
    Horii, Rie
    Toi, Masakazu
    Sasano, Hironobu
    CANCER SCIENCE, 2013, 104 (11) : 1539 - 1543
  • [3] Ki67 assessment in breast cancer: an update
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    PATHOLOGY, 2017, 49 (02) : 166 - 171
  • [4] Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
    Dowsett, Mitch
    Nielsen, Torsten O.
    A'Hern, Roger
    Bartlett, John
    Coombes, R. Charles
    Cuzick, Jack
    Ellis, Matthew
    Henry, N. Lynn
    Hugh, Judith C.
    Lively, Tracy
    McShane, Lisa
    Paik, Soon
    Penault-Llorca, Frederique
    Prudkin, Ljudmila
    Regan, Meredith
    Salter, Janine
    Sotiriou, Christos
    Smith, Ian E.
    Viale, Giuseppe
    Zujewski, Jo Anne
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22): : 1656 - 1664
  • [5] Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
    Nielsen, Torsten O.
    Leung, Samuel C. Y.
    Rimm, David L.
    Dodson, Andrew
    Acs, Balazs
    Badve, Sunil
    Denkert, Carsten
    Ellis, Matthew J.
    Fineberg, Susan
    Flowers, Margaret
    Kreipe, Hans H.
    Laenkholm, Anne-Vibeke
    Pan, Hongchao
    Penault-Llorca, Friderique M.
    Polley, Mei-Yin
    Salgado, Roberto
    Smith, Ian E.
    Sugie, Tomoharu
    Bartlett, John M. S.
    McShane, Lisa M.
    Dowsett, Mitch
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 808 - 819
  • [6] A novel model for Ki67 assessment in breast cancer
    Quinci Romero
    Pär-Ola Bendahl
    Mårten Fernö
    Dorthe Grabau
    Signe Borgquist
    Diagnostic Pathology, 9
  • [7] An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
    Rimm, David L.
    Leung, Samuel C. Y.
    McShane, Lisa M.
    Bai, Yalai
    Bane, Anita L.
    Bartlett, John M. S.
    Bayani, Jane
    Chang, Martin C.
    Dean, Michelle
    Denkert, Carsten
    Enwere, Emeka K.
    Galderisi, Chad
    Gholap, Abhi
    Hugh, Judith C.
    Jadhav, Anagha
    Kornaga, Elizabeth N.
    Laurinavicius, Arvydas
    Levenson, Richard
    Lima, Joema
    Miller, Keith
    Pantanowitz, Liron
    Piper, Tammy
    Ruan, Jason
    Srinivasan, Malini
    Virk, Shakeel
    Wu, Ying
    Yang, Hua
    Hayes, Daniel F.
    Nielsen, Torsten O.
    Dowsett, Mitch
    MODERN PATHOLOGY, 2019, 32 (01) : 59 - 69
  • [8] Ki67 Assessment in Breast Cancer: Are We There Yet?
    Reis-Filho, Jorge S.
    Davidson, Nancy E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 797 - 798
  • [9] The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer
    Rewcastle, Emma
    Skaland, Ivar
    Gudlaugsson, Einar
    Fykse, Silja Kavlie
    Baak, Jan P. A.
    Janssen, Emiel A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (01) : 1 - 12
  • [10] A novel model for Ki67 assessment in breast cancer
    Romero, Quinci
    Bendahl, Par-Ola
    Ferno, Marten
    Grabau, Dorthe
    Borgquist, Signe
    DIAGNOSTIC PATHOLOGY, 2014, 9